-+ 0.00%
-+ 0.00%
-+ 0.00%

CHEMOMAB THERAPEUTICS- REINFORCES AND EXPANDS POSITIVE RESULTS FROM 15-WEEK DOUBLE-BLIND PHASE 2 SPRING TRIAL

Reuters·03/27/2025 12:30:01

Please log in to view news